Evidence map›Paper›PMID 29276057›Full record

Trial reportGynecologic oncology2018

Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.

J R Montealegre, E C Peckham-Gregory, D Marquez-Do, L Dillon, M Guillaud, K Adler-Storthz, M Follen, M E Scheurer

Open access · greenAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Gynecologic oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

J R MontealegreDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA. Electronic address: jrmontea@bcm.edu.
E C Peckham-GregoryDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
D Marquez-DoDan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
L DillonResearch Service Line, Michael E DeBakey VA Medical Center, Houston, TX, USA.
M GuillaudDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
K Adler-StorthzDepartment of Diagnostic and Biomedical Sciences, University of Texas School of Dentistry, Houston, TX, USA.
M FollenDepartment of Obstetrics and Gynecology, Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.
M E ScheurerDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Children's Cancer Center · USBaylor College of Medicine · USBrookdale University Hospital and Medical Center · USMichael E. DeBakey VA Medical Center · USOccupational Cancer Research Centre · CA

Funding

Technical FeasibilityP01CA082710 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GUILLAUD, MARTIAL · 1999 to 2014
$28.7M
Training Program in Pediatric Cancer Epidemiology and ControlR25CA160078 · NCI · BAYLOR COLLEGE OF MEDICINE · PI BONDY, MELISSA L., CHANG, SHINE · 2011 to 2015
$1.9M
Nonhomologous end-joinging polymorphisms and HPV integration in cervical dysplasiR03CA143965 · NCI · BAYLOR COLLEGE OF MEDICINE · PI SCHEURER, MICHAEL E. · 2009 to 2010
$154k
NCI NIH HHS P01 CA082710NCI NIH HHS R03 CA143965NCI NIH HHS R25 CA160078
6 · The paper itself

Abstract

objectiveHPV genotype distribution varies by race/ethnicity, but is unclear whether there are racial/ethnic variations in HPV 16/18 integration in the host genome. We describe HPV16/18 infection and integration status in a racially/ethnically diverse sample of women with a recent abnormal Pap test.

methodsPatients (n=640) represent a subset of women participating in a clinical trial. Cervical swabs were tested for HPV16/18 DNA using type-specific polymerase chain reaction assays. Viral integration status was assessed using type-specific integration assays and categorized as fully integrated, fully non-integrated, or mixed. Unconditional logistic regression was used to generate unadjusted (OR) and adjusted odds ratios (aOR) to assess the association between self-reported race/ethnicity and risk of these outcomes.

resultsHispanic and non-Hispanic black women had half the odds of prevalent HPV16 compared to non-Hispanic white women (aORs: 0.43 and 0.45, respectively). The prevalence odds of HPV18 was less than half among Hispanic women (aOR: 0.48), but not significantly different between black and white women (aOR: 0.72). Among women with prevalent HPV16, the odds of fully integrated viral DNA were significantly higher among black women (aORs: 2.78) and marginally higher among Hispanic women (aOR: 1.93). No racial/ethnic differences were observed for HPV18 DNA integration.

conclusionsWhile HPV16 and 18 infections were less prevalent among Hispanic and black women compared to whites, their HPV16 DNA was more likely to be present in a fully integrated state. This could potentially contribute to the higher rates of abnormal cytology and cervical dysplasia observed among Hispanic and black women.

Indexed as

AdolescentAdultAgedBlack or African AmericanCanadaDNA, ViralFemaleGenotypeHispanic or LatinoHuman papillomavirus 16Human papillomavirus 18HumansMiddle AgedPapillomavirus InfectionsPrevalenceUnited StatesDNA, ViralHPV16HPV18Human papillomavirusRace/ethnicityViral integration

Identifiers

PMID29276057
PMCPMC5801201
OpenAlexW2776318570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.